Insulin pens withdrawn

KwikPen device supersedes Humulin and Humalog prefilled pens
KwikPen device supersedes Humulin and Humalog prefilled pens

Lilly has completed its planned withdrawal of the Humulin and Humalog prefilled insulin pens.

Humulin I, Humulin M3, Humalog, Humalog Mix25 and Humalog Mix50 all continue to be available in the newer prefilled ‘KwikPen’ device. In most cases, transition to the KwikPen should have already taken place as part of patients’ regular treatment review.

Further Information: Lilly Eli & Co Ltd

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Check on the latest drug supply issues with MIMS' shortages...

Novel MS drug gains NICE approval

Novel MS drug gains NICE approval

New NICE guidance recommends ocrelizumab (Ocrevus)...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

NICE recommends new triple therapy option for diabetes

NICE recommends new triple therapy option for diabetes

Ertugliflozin (Steglatro) can now be prescribed routinely...